comparemela.com
Home
Live Updates
Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster : comparemela.com
Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster
Press release content from Business Wire. The AP news staff was not involved in its creation.
Related Keywords
India
,
Netherlands
,
Groningen
,
Massachusetts
,
United States
,
Linda Pendergast
,
Todd Zion
,
Schelto Kruijff
,
Johnson Janssen
,
Akston Biosciences
,
Akston Bioscience
,
Akston Biosciences Corporation
,
Birnbach Communications For Akston Biosciences
,
Merck Co
,
University Medical Center Groningen
,
Pfizer
,
Dechra Pharmaceuticals
,
Astrazeneca
,
Clinical Research Organization
,
Smartcells Inc
,
Rapid Cure Task Force
,
Biosciences Corporation
,
Business Wire
,
Receptor Binding Domain
,
Cure Task Force
,
Covid 19
,
Health
,
Clinical Trials
,
Beverly
,
comparemela.com © 2020. All Rights Reserved.